Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Greenrise Global Brands Inc C.XCX

Alternate Symbol(s):  GRGBF

Greenrise Global Brands Inc. is a Canada-based investment holding company. The Company holds investments in the German cannabis industry. The Company has investments in CannaCare Health GmbH, a Germany-based company with operations in cannabidiol (CBD) sales predominantly in Germany.


CSE:XCX - Post by User

User Avatar Image
(3)
•••
  • StockwonderX
Post by Stockwonderon Dec 16, 2020 5:31am
268 Views
Post# 32116582

AMP German Cannabis: Letter to Shareholder - Preview 2021

AMP German Cannabis: Letter to Shareholder - Preview 2021AMP is ready for german & european market.

'The upcoming year will be transformational for AMP and the medical cannabis industry in Germany and globally.'


'...in December, the European Union (EU) removed all uncertainty that cannabis with CBD and THC below 0.2% is not a narcotic, which may result in these wellness products being sold without a prescription in Germany and Europe.'

'...AMP import licences for medical cannabis products imported from outside and within the EU into Germany'

'...also received an AmRadV license, which allows us to import irradiated cannabis products from within and outside the EU, which have undergone microbial germ reduction from The Federal Institute for Drugs and Medical Devices (BfArM). '

'...building a strong sales team with the objective to have national coverage'

Click here to read LETTER to shareholders! 
<< Previous
Bullboard Posts
Next >>